User profiles for M. Farrer
Matt FarrerUniversity of Florida Verified email at can.ubc.ca Cited by 57490 |
Missing pieces in the Parkinson's disease puzzle
Parkinson's disease is a neurodegenerative process characterized by numerous motor and
nonmotor clinical manifestations for which effective, mechanism-based treatments remain …
nonmotor clinical manifestations for which effective, mechanism-based treatments remain …
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer - Nature Reviews Genetics, 2006 - nature.com
Parkinson disease is a complex, multifactorial neurodegenerative disease. Although a heritable
basis was originally thought unlikely, recent studies have implicated several genes in its …
basis was originally thought unlikely, recent studies have implicated several genes in its …
LRRK2 in Parkinson's disease: protein domains and functional insights
IF Mata, WJ Wedemeyer, MJ Farrer, JP Taylor… - Trends in …, 2006 - cell.com
Parkinson's disease (PD) is the most common motor neurodegenerative disease. Mutations
in the gene encoding leucine-rich repeat kinase 2 (LRRK2) have been linked recently with …
in the gene encoding leucine-rich repeat kinase 2 (LRRK2) have been linked recently with …
α-Synuclein locus triplication causes Parkinson's disease
We examined a large family with autosomal dominant PD (average age of onset, 34 years),
ranging clinically from dementia with Lewy bodies to typical PD (3). Neuropathological …
ranging clinically from dementia with Lewy bodies to typical PD (3). Neuropathological …
α-synuclein locus duplication as a cause of familial Parkinson's disease
… MC Chartier-Harlin and M Farrer designed and supervised the work and wrote the manuscript.
A Destée and P Amouyel helped coordinate the study. All investigators revised the report …
A Destée and P Amouyel helped coordinate the study. All investigators revised the report …
[HTML][HTML] Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
…, M Farrer, S Lincoln, J Kachergus, M Hulihan… - Neuron, 2004 - cell.com
We have previously linked families with autosomal-dominant, late-onset parkinsonism to
chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and …
chromosome 12p11.2-q13.1 (PARK8). By high-resolution recombination mapping and …
[HTML][HTML] Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease
Background Recent studies indicate an increased frequency of mutations in the gene
encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among …
encoding glucocerebrosidase (GBA), a deficiency of which causes Gaucher's disease, among …
[PDF][PDF] VPS35 mutations in Parkinson disease
…, RJ Uitti, ZK Wszolek, F Vingerhoets, MJ Farrer - The American Journal of …, 2011 - cell.com
The identification of genetic causes for Mendelian disorders has been based on the collection
of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals…
of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals…
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
M Farrer, J Kachergus, L Forno… - Annals of Neurology …, 2004 - Wiley Online Library
Genomic triplication of the α‐synuclein gene recently has been associated with familial
Parkinson's disease in the Spellman–Muenter kindred. Here, we present an independent family, …
Parkinson's disease in the Spellman–Muenter kindred. Here, we present an independent family, …
Alpha‐synuclein p. H50Q, a novel pathogenic mutation for Parkinson's disease
…, AH Rajput, A Jon Stoessl, MJ Farrer - Movement …, 2013 - Wiley Online Library
… Farrer has received speaker fees from Genetech and Teva; occasionally consults with Isis
Pharamaceuticals, H. Lundbeck A/S, and GlaxoSmithKline; receives royalties for patents held …
Pharamaceuticals, H. Lundbeck A/S, and GlaxoSmithKline; receives royalties for patents held …